Evidence map›Paper›PMID 37607197›Full record

ArticlePloS one2023

Development of a Core Outcome Set for the research and assessment of inoperable malignant bowel obstruction.

Alison Bravington, George Obita, Elin Baddeley, Miriam J Johnson, Fliss E M Murtagh, David C Currow, Elaine G Boland, Annmarie Nelson, Kathy Seddon, Alfred Oliver and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Alison BravingtonWolfson Palliative Care Research Centre, Hull York Medical School, University of Hull, Hull, United Kingdom.ORCID 0000-0002-0680-2093
George ObitaDove House Hospice, Hull, England, United Kingdom.
Elin BaddeleyMarie Curie Palliative Care Research Centre, Cardiff University, Cardiff, United Kingdom.
Miriam J JohnsonWolfson Palliative Care Research Centre, Hull York Medical School, University of Hull, Hull, United Kingdom.ORCID 0000-0001-6204-9158
Fliss E M MurtaghWolfson Palliative Care Research Centre, Hull York Medical School, University of Hull, Hull, United Kingdom.
David C CurrowFaculty of Science, Medicine and Health, University of Wollongong, Wollongong, NSW, Australia.
Elaine G BolandHull University Teaching Hospitals NHS Trust, Hull, United Kingdom.
Annmarie NelsonMarie Curie Palliative Care Research Centre, Cardiff University, Cardiff, United Kingdom.
Kathy SeddonMarie Curie Palliative Care Research Centre, Cardiff University, Cardiff, United Kingdom.
Alfred OliverNational Cancer Research Institute, Consumer Liaison Group, Trans-Humber Consumer Research Panel, London, United Kingdom.
Simon I R NobleMarie Curie Palliative Care Research Centre, Cardiff University, Cardiff, United Kingdom.
Jason W BolandWolfson Palliative Care Research Centre, Hull York Medical School, University of Hull, Hull, United Kingdom.
Marie Curie Palliative Care Institute Liverpool · GBUniversity of Hull · GBNational Cancer Research Institute · GBTrinity House · GBUniversity of Wollongong · AU

Funding

Marie Curie MCCC-FCO-11-CMarie Curie MCRGS-20171220-8020
6 · The paper itself

Abstract

backgroundMalignant bowel obstruction is experienced by 15% of people with advanced cancer, preventing them from eating and drinking and causing pain, nausea and vomiting. Surgery is not always appropriate. Management options include tube or stent drainage of intestinal contents and symptom control using medication. Published literature describing palliative interventions uses a broad range of outcome measures, few of which are patient-relevant. This hinders evidence synthesis, and fails to consider the perspectives of people undergoing treatment.

aimsTo develop a Core Outcome Set for the assessment of inoperable malignant bowel obstruction with clinician, patient and caregiver involvement, using COMET methodology (Core Outcome Measures in Effectiveness Trials).

methodsA systematic review of clinical trials and observational studies, a rapid review of the qualitative literature and in-depth patient and clinician interviews were conducted to identify a comprehensive list of outcomes. Outcomes were compared and consolidated by the study Steering Group and Patient and Public Involvement contributors, and presented to an international clinical Expert Panel for review. Outcomes from the finalised list were rated for importance in a three-round international Delphi process: results of two survey rounds were circulated to respondents, and two separate consensus meetings were conducted with clinicians and with patients and caregivers via virtual conferencing, using live polling to reach agreement on a Core Outcome Set.

results130 unique outcomes were identified. Following the independent Expert Panel review, 82 outcomes were taken into round 1 of the Delphi survey; 24 outcomes reached criteria for critical importance across all stakeholder groups and none reached criteria for dropping. All outcomes rated critically important were taken forward for re-rating in round 2 and all other outcomes dropped. In round 2, all outcomes were voted critically important by at least one stakeholder group. Round 2 outcomes were presented again at online consensus meetings, categorised as high ranking (n = 9), middle ranking (n = 7) or low ranking (n = 8). Stakeholders reached agreement on 16 core outcomes across four key domains: Symptom control, Life impact, Treatment outcomes, and Communication and patient preferences.

conclusionUse of this Core Outcome Set can help to address current challenges in making sense of the evidence around treatment for inoperable malignant bowel obstruction to date, and underpin a more robust future approach. Clearer communication and an honest understanding between all stakeholders will help to provide a basis for responsible decision-making in this distressing situation in clinical practice.

Indexed as

CommunicationDrainageConsensusGastrointestinal ContentsHumansNausea

Identifiers

PMID37607197
PMCPMC10443874
OpenAlexW4386082895

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.